MAFFEI, PIETRO

MAFFEI, PIETRO  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 150 (tempo di esecuzione: 0.052 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
The paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism 2025 Occhi, GVoltan, GMaffei, PDassie, FScaroni, CCeccato, F + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas 2024 Maffei P + GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT - -
Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations 2024 Maffei, Pietro + EUROPEAN JOURNAL OF HUMAN GENETICS - -
Consensus on criteria for acromegaly diagnosis and remission 2024 Maffei, Pietro + PITUITARY - -
Copeptin after pituitary surgery: is it worth measuring? 2024 Maffei, Pietro + PITUITARY - -
Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 2024 Dassie, FrancescaMaffei, Pietro + ENDOCRINE CONNECTIONS - -
GH Excess: Medical Treatment of Acromegaly: What’s New? 2024 Pietro MaffeiFrancesca Dassie - - GH Excess and Deficiency from Fetus to Older Age: A Kaleidoscopic Overview
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management 2024 Maffei, P. + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes 2024 Maffei, Pietro + THE LANCET DIABETES & ENDOCRINOLOGY - -
Medical Treatment of Acromegaly: What's New? 2024 Maffei, PietroDassie, Francesca Frontiers of Hormone Research - -
Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1 2024 Maffei, Pietro + THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM - -
Real-life data of Pasireotide LAR in acromegaly: a long-term follow-up 2024 Dassie, F.Maffei, P. + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome 2023 Dassie, FrancescaAlbiero, MattiaBettini, SilviaCappellari, RobertaMilan, GabriellaCiciliot, StefanoAvogaro, AngeloVettor, RobertoMaffei, PietroFadini, Gian Paolo + ENDOCRINOLOGY - -
Italian Guidelines for the Management of Prolactinomas 2023 Maffei P + ENDOCRINE, METABOLIC & IMMUNE DISORDERS DRUG TARGETS - -
SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations 2023 Maffei, PietroBettini, SilviaBusetto, LucaDassie, Francesca DIABETES, METABOLIC SYNDROME AND OBESITY - -
Skin manifestations in rare types of diabetes and other endocrine conditions 2023 Dassie, FrancescaMaffei, Pietro + ENDOCRINE CONNECTIONS - -
The Italian registry for patients with Prader-Willi syndrome 2023 Maffei, PietroDassie, Francesca + ORPHANET JOURNAL OF RARE DISEASES - -
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY 2022 Dassie, FMaffei, P + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -
Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome 2022 Dassie, FrancescaMilan, GabriellaMaffei, Pietro + FRONTIERS IN GENETICS - -
GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study 2022 Dassie F.Maffei P. + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -